Global Rivaroxaban Sales Market Report 2018

The Global Rivaroxaban Sales market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and opportunities along with their impact on the Rivaroxaban Sales market growth. This research report will assist in being relevant and future-oriented, while improving decision-making capabilities and reducing market risk. It is an excellent way to find the best market or target demographic for a product or service.

The report gives detailed overview of the products and segments the market as per application/ type/ regions/ end user (as applicable). The study evaluates the Global market on the basis of current and past sales, revenue, capacity, and production status. The future outlook and prospects are then derived with the help of industry experts.

Furthermore, the research report also helps to understand the comprehensive profiles of the key players in the market and in-depth view of the competitive landscape worldwide.

This report studies the global Rivaroxaban market status and forecast, categorizes the global Rivaroxaban market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 812 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

The global Rivaroxaban market is valued at 5860 million US$ in 2017 and will reach 11000 million US$ by the end of 2025, growing at a CAGR of 8.2% during 2018-2025.

The major players covered in this report

• Bayer
• J&J

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 2.5 mg
• 10 mg
• 15 mg
• 20 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Acute Coronary Syndrome (ACS)
• Venous Thromboembolism (VTE)

The study objectives of this report are:

• To analyze and study the global Rivaroxaban sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Rivaroxaban players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Rivaroxaban are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

• Rivaroxaban Manufacturers
• Rivaroxaban Distributors/Traders/Wholesalers
• Rivaroxaban Subcomponent Manufacturers
• Industry Association
• Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Rivaroxaban market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents-Snapshot
1 Market Overview
2 Global Competition by Players/Suppliers, Type and Application
3 United States (Volume, Value and Sales Price)
4 China (Volume, Value and Sales Price)
5 Europe (Volume, Value and Sales Price)
6 Japan (Volume, Value and Sales Price)
7 Southeast Asia (Volume, Value and Sales Price)
8 India (Volume, Value and Sales Price)
9 Global Players/Suppliers Profiles and Sales Data
10 Manufacturing Cost Analysis
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
13 Market Effect Factors Analysis
14 Global Market Forecast (2018-2025)
15 Research Findings and Conclusion
16 Appendix